PGI doctor to head American body

Tribune News Service

Chandigarh, June 13

Dr Navneet Singh, Additional Professor in the Department of Pulmonary Medicine at the PGIMER, has been invited to assume the role of the chair of the IDEA Working Group of the American Society of Clinical Oncology (ASCO).

The ASCO is the world’s largest professional body with a global network of nearly 45,000 oncology professionals (individuals working in the area of cancer care). It is a leading resource provider for the practice of clinical oncology in both academic and community settings as well as for the oncology research.

Dr Singh took over as the chair at the 54th annual meeting of the ASCO held in the first week of June at Chicago, USA. He will hold this position for two years. Dr Singh leads the multidisciplinary thoracic oncology group at the PGIMER and specialises in thoracic medical oncology, especially targeted therapies and immunotherapy, for advanced/metastatic non-small cell lung cancer (NSCLC). He is an invited member of the ASCO’s Thoracic Cancer Guideline Advisory Group and was part of the development of guidelines for molecular testing in the NSCLC which have been recently published in the Journal of Clinical Oncology. 

He works closely with the International Association for Study of Lung Cancer (IASLC) – another global organisation dedicated to lung cancer. 

With over 150 publications to his credit, Dr Singh has been a recipient of several awards and honours for his research in the area of lung cancer, including the Kamal Satbir Award of the Indian Council for Medical Research (ICMR) in 2014.